CD33 and Alzheimer disease: Initially, genome-wide association studies identified a single nucleotide polymorphism in the promoter region of the CD33 gene, rs3865444, whose minor allele is associated with a modestly protective effect on AD susceptibility and reduced CD33 expression [10,11,12].